One, Two, Infinity Genomes Filled with Aptamers by Gold, Larry et al.
Chemistry & Biology, Vol. 9, 1259–1264, December, 2002, 2002 Elsevier Science Ltd. All rights reserved. PII S1074-5521(02)00286-7
Matters ArisingOne, Two, Infinity:
Genomes Filled with Aptamers
One, Two the modern basis of catalysis, a contemporaneous parti-
tioning of function could have left cofactors free of oligo-Individual cells limit production of unnecessary meta-
bolic capacities by monitoring their immediate environ- nucleotides (to function as aids to the proteins that
needed them for catalysis) and left oligonucleotides freement and regulating gene expression appropriately. This
presumably results in greater efficiency and energy utili- to encode proteins. White predicted an earlier world in
which “shapes and tapes” were found in the same an-zation while allowing rapid response to environmental
changes. Cells respond to changes in individual metab- cient molecules, and that division of labor led to a sim-
pler code (only four simple nucleotides) and better cata-olites such as carbon and nitrogen sources or vitamins
by regulating expression of genes necessary for synthe- lysts (proteins with cofactors, which were free to evolve
or not, but were no longer bound by the rules for oligonu-sis or utilization of the specific metabolite. Curiously,
although the ultimate chemical signal to which cells re- cleotides). White had a substantial vision into what we
now call the “RNA world,” although he did not claim thespond is the metabolite itself, until now the regulatory
factotum usually has been a protein. idea as conclusively as did Gilbert [8]. Because these
two examples in E. coli of aptamer activity within anRon Breaker and his colleagues [1, 2] have published
two papers that demonstrate regulation of translation mRNA are in the context of expression systems that
participate in the synthesis of cofactors, Breaker inter-through direct interaction of a small molecule metabolite
with mRNAs encoding proteins necessary for their up- prets his findings as a reflection of the world that was.
We love Harold B. White’s and Ron Breaker’s work,take or utilization. In the first paper, the btuB leader
sequence, 5 to the translational initiation domain for yet we wonder if remnants are less important to this
discussion than continuous selection for coordinatedbtuB, interacts directly with coenzyme B12 in such a way
as to cause structural changes to the RNA that sequester regulation over the last several billion years, well after
Harold B. White’s cofactors had left their previous oligo-the translational initiation domain from ribosome inspec-
tion. The btuB gene encodes the receptor by which B12 nucleotide homes.
Infinityis transported into the cell. Hence, the impact of this
regulatory loop is to reduce synthesis of the transporter A more dramatic extrapolation of the findings would be
to wonder if these two examples in E. coli reflect a richwhen intracellular B12 levels are sufficient. In the second
paper, the 5 leaders of thiM and thiC mRNAs are shown world of regulatory phenomena involving RNAs express-
ing their “shape” coincidentally with their “tape”—thatto bind directly to thiamine (vitamin B1), again leading to
an mRNA structural alteration such that the biosynthetic is, can we wonder if genomes encode large numbers of
aptamers to alter metabolic pathways? Explicitly, weenzymes are depressed (translationally) when the intra-
cellular thiamine levels are sufficient. The mechanisms wish to consider the evolutionary pressures for a variety
of aptamers that do exactly what Breaker has found,for the translational repression are not known with cer-
tainty, but one can deduce the most likely scenarios. In and to consider as well the organisms in which we are
likely to find the phenomenon most frequently. We willE. coli, translation is initiated by a ribosomal interaction
with the Shine and Dalgarno region/initiation codon of conclude that these regulatory phenomena are even
more important in the eukaryotes.an mRNA as well as initiator tRNA and initiation factors
[3, 4]. The easiest way to currently understand the two Aptamer Review 101
Let us first spend a few moments reviewing the SELEXB-vitamin regulatory mechanisms described by Break-
er’s group is to imagine an mRNA with two alternative protocol [9, 10] through which nonnatural aptamers are
identified (Figure 2). Double-stranded DNA with a ran-structures, open and closed, in equilibrium. The open
structure allows translational initiation, while the closed domized sequence region is prepared chemically. One
strand is synthesized with flanking fixed regions (for PCRhides the Shine and Dalgarno region from the ribosome
(using different intramolecular base pairing). If the me- or other amplification), and the complementary stand is
prepared enzymatically. If the synthetic DNA is preparedtabolite is preferentially recognized by the closed struc-
ture, thus altering the equilibrium, translation initiation on a 10 mol scale, and 1 mol of final product is ob-
tained, the starting library may contain about 6  1017will be lowered (Figure 1). Exactly the same principles
can alter other mRNA (and pre-mRNA) functions (to be unique sequences (when the random region is longer
than about 30 nucleotides). The double-stranded se-discussed later; Figures 1 and 4). These two systems de-
scribed by Breaker represent a novel appreciation of the quence library (tape) is converted enzymatically to a
single-stranded (DNA, RNA, or modified oligonucleo-power of mRNA functional capacities, leading us to won-
der (once again [5, 6]) how far such RNA magic may go. tide) shape library from which shapes with desired prop-
erties are selected. Because the flanking sequencesThe authors interpret their data in the glow of work
by Harold B. White III [7]. White observed more than 20 allow amplification of culled “winners,” one can perform
multiple rounds of enrichment, and eventually most tar-years ago that many of the present nucleotide cofactors
might have been among the nucleotides present in an- gets yield an aptamer. In many ways, the SELEX protocol
is merely the single-stranded oligonucleotide version ofcient RNA or DNA, thus providing oligonucleotides with
both coding and catalytic capacities. He proposed, ex- phage, ribosome, or mRNA display for peptides and
larger proteins [11–14]. The primary difference is thatplicitly, that as the protein world emerged and became
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Figure 1. Breaker’s Metabolic Feedback
Regulation of Translation and a Generaliza-
tion to Other mRNA Regulatory Pathways
Sequences A and C are complementary to
sequence B. When the structure stabilized by
A-B pairing is formed, the translation initiation
sequences are available to the ribosome and
translation proceeds. In the presence of me-
tabolite, the structure stabilized by B-C pair-
ing is favored, and the initiation region is un-
available to the ribosome.
Substituting other regulator sequences for
the Shine-Dalgarno translation initiation se-
quence in this example allows the identical
mechanism to moderate accessibility of other
complexes necessary to effect processes
such as splicing, termination, etc.
the identified aptamer is an oligonucleotide rather than a aptamer ever identified for a protein target may be the
vascular endothelial growth factor (VEGF) aptamer thatprotein. Bruce Eaton has said repeatedly in his seminars
that RNA/aptamer scientists must suffer from “side is presently in its pivotal clinical trial for macular degen-
eration; that molecule, now called Macugen by EyeTechgroup envy” (B. Eaton, personal communication).
The length of the random regions in classical SELEX Pharmaceuticals (http://www.eyetk.com), is but 28 nu-
cleotides long, has an approximately 50 pM Kd, bindsexperiments is small [15–18]. At NeXstar, we focused
on finding aptamers for therapeutics that could be syn- to VEGF with high specificity, and prevents VEGF from
binding to its receptors [19].thesized at reasonable cost, and tended to use 30 to
40 random positions in a starting SELEX library. This was It is true that most aptamers have been selected from
very large starting libraries of oligonucleotide se-a compromise: longer single-stranded oligonucleotides
must provide more shape opportunities than shorter quences, substantially larger than the sequence space
available in modern genomes (SELEX starting librariesoligonucleotides, but we knew that the cost of aptamer
drugs would be high and a function of their length. Some can be as large as 1015 unique molecules, about 105
times more than the human genome.). However, SELEXSELEX experiments were performed with libraries con-
taining up to 200 randomized positions, even though no experiments are done in a week with 5 to 15 rounds of
selection, while evolution and selection in biology hadaptamer derived from a long randomized region ever
requires all or even most of the nucleotides of that ap- a billion years with perhaps a “round” of selection every
day; the point is that 1011 divisions during unicellulartamer to do the binding. In fact, no strong published
data show that smaller randomized regions would have growth can more than make up, via mutation, for a
smaller starting library (the genome).failed to yield an equivalent aptamer. The best short
We know a great deal today about aptamers that have
been selected against protein targets and also against
small molecule (metabolite) targets [20, 21]. RNA apta-
mers have Kds between 10 nM and 10 pM for proteins
(which are present usually in cells at concentrations
between M and nM), while aptamer Kds are between
10 M and 10 nM for small molecules (which are present
usually in cells at concentrations far higher than protein
concentrations, perhaps mM toM). Aptamers that have
been selected in vitro seem ideally suited for interacting
with proteins or small molecules at their physiological
concentrations. This leads to wondering whether ap-
tamer selection occurs frequently in vivo, leading to
flagrant use of aptamers in all creatures.
Genomes Filled with Aptamers: Background
The first natural aptamer discovered in biology probably
was the lac operator, although that “aptamer” consisted
of double-stranded DNA. However, the large number ofFigure 2. The Classic SELEX Protocol, Leading to Selection of Ap-
tamers DNA sites to which specific proteins bind does reflect
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our first principle: evolution can demand and get tight repeatedly, yet never make this point more exquisitely
than Jacob made it more than 25 years ago [33].).and specific binding between genomic nucleic acid se-
quences and proteins. These observations are not restricted to bacteria.
Years ago, Klausner and his colleagues described natu-The second class of natural single-stranded RNA ap-
tamers (and the first sites that really were aptamers) ral aptamers at the 5 or the 3 ends of mRNAs that
could impact translation or mRNA stability [34–36], inwere discovered in the small E. coli RNA phages MS2,
R17, and Q [22–24]. These phage face serious regula- either case altering the protein output by a feedback
mechanism dependent on iron regulatory protein (IRP),tory problems (such as clearing the input RNA genome
of ribosomes before replication of the plus strand [to which binds IREs (iron-responsive elements) in mRNA
only in iron-depleted cells. Similarly, the number of pro-make a minus strand] results in a lethal collision between
two immovable objects), and the phage all evolved won- teins thought to enhance or repress splicing is growing;
aptamer sequences near exon-intron or intron-exonderful binding sites comprising folded RNAs that al-
lowed tight and specific binding of proteins; these sites junctions give splicing a remarkable flexibility and coor-
dination with metabolism. In Saccharomyces cerevisiae,are natural aptamers. Oddly, these fascinating viral RNA
structures often were seen as the best these poor crea- ribosomal protein L30 binds to a 36 nucleotide bulged
stem-loop in rRNA. Excess L30 binds to a similar stem-tures could do because they had no chance to use
transcriptional regulation. (People actually said in the loop structure containing the 5 splice site in L30 pre-
mRNA and inhibits utilization of this splice site. A further1970s and 1980s [in print] that translational regulation
would not occur in an organism that had a chance to twist on aptamer use in this system is the finding that
the translation initiation AUG of L30 mRNA is alsoregulate gene expression transcriptionally.) Transla-
tional regulation was discovered in the bacteriophage wrapped up in a similar structure, so that excess L30
protein autogenously regulates both splicing and trans-T4 (which has a real DNA genome): T4 gene 32 protein
regulates its own translation, T4 gene 43 protein regu- lation during gene expression [37, 38]. Splicing control
in metazoans is even richer in aptamer like modulatinglates its own translation, and T4 regA protein regulates
the translation of twenty or so mRNAs [25–28]. The sites sequences. Intronic enhancers [39] and exonic en-
hancers [40] participate in a cascade of sex-dependentresponsible for translational regulation were called
“translational operators” (a phrase chosen from tran- splicing events in the development of Drosophila mela-
nogaster. In mammals, splicing regulation seems to bescription envy), but these sites are natural aptamers. A
similar set of natural aptamers has been identified in E. the norm rather than the exception. It is now clear that
SR proteins, a group that had been previously lumpedcoli: several ribosomal proteins were found to regulate
their own translation by binding to the ribosome binding together as one class because of their serine-arginine
repeats, actually bind to individual aptamer sequences insites on their cognate mRNAs. Usually the proteins that
regulated their own synthesis were proteins with binding exons to give exquisitely fine-tuned splicing patterns [41].
We note that when aptamers are selected againstsites for specific sites in ribosomal RNA, and thus the
mRNA aptamers were thought to be mere mimics of proteins that bind to natural aptamers, the resulting arti-
ficial aptamer (which is always short compared to thethat functional binding site [29, 30]. Nevertheless, one
saw creeping into the literature mRNA sequences that genomic window of opportunity) may not (and usually
does not) resemble the natural aptamer. This is really(usually) were secondary sites that helped prevent ex-
cessive synthesis of specific proteins [31]. This type of not more than a statement that complex structures can
utilize long-range RNA interactions that cannot happenautogenous translational repression is now quite
common. in a randomized sequence only 30 or 40 nucleotides in
length, although it must also be remembered that natureWe think of transcriptional attenuation in bacteria as
an example of regulatory events caused by a natural selects for optimal sequences (with respect to physio-
logical needs), whereas artificial SELEX chooses maxi-aptamer; the aptamer comprises specific codons within
an mRNA [32]. When a ribosome is translating the 5 mal binding affinity.
The presence of many natural aptamers that serve toend of a polycistronic mRNA that encodes the enzymes
needed for the biosynthesis of an amino acid, codons control protein expression is the intellectual space
within which the Breaker papers reside. The startlingin the leader peptide are recognized by the cognate
aminoacylated tRNA (during translation) if the amino element in the Breaker papers derives from the fact
that the feedback inhibition occurs in response to theacid is present in sufficient quantities; those codons are
not recognized if that amino acid concentration is too concentration of a small molecule rather than a protein,
even though the specificity and affinity data for syntheticlow. Translation of the leader peptide causes the re-
maining polycistronic mRNA to not be transcribed, thus aptamers aimed at small molecules is so robust (see
[21] for a wonderful review). RNA binding activities (assignaling to the operon that additional biosynthetic en-
zymes are not needed. This example of feedback repres- aptamers) can be generalized to include “open” and
“closed” forms of attenuator sequences [32], splicingsion operates through an mRNA-amino acid recognition
(thus an aptamer for the amino acid, sort of), but the elements [37, 38], transcriptional termination sites [42],
frame-shifting sequences [43], nuclear exit determinantsactual mechanics of feedback involve the tRNA, the
aminoacyl-tRNA synthetase, and the entire ribosome. [44, 45], RNA decay elements [46], etc.; that is, any RNA
might fold into two states in equilibrium, such that theThere exist many other (far simpler) ways to have high
amino acid concentration direct lower synthesis of the perturbation of that equilibrium by an aptamer-specific
ligand can have a regulatory impact (Figure 1) which isrequisite enzymes for amino acid synthesis, but evolu-
tion takes what it can get (We will return to this point manifested through either more or less RNA, more or
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thought, even though for sure they would agree about
almost everything in detail; each has made points that
live comfortably within the other’s worlds, once time is
allowed into the dialog [48].
Why are we speaking about Jacob and Savageau?
The regulation of gene expression is an area in which
many quasi-equivalent/quasi-different solutions appear
quasi-robust. This explains the extraordinarily different
mechanisms by which bacterial phages control tran-
scription during their developmental programs [49]; that
is, evolutionary pressures cannot drive bacteriophages
to all use the same mechanism because several bio-
chemical mechanisms are equivalently robust (at least
approximately equivalent). Thus, we need to understand
the pressures that might allow Breaker’s observations
to be commonplace: once again can we extrapolate
from two to infinity.
Coordination of Metabolic Capacity
Organisms struggle to utilize their biochemistry effi-
ciently by coordinating vast numbers of different mole-Figure 3. The Three Kingdoms of Life, Evolving from an All Monocis-
tronic (mc) World into Polycistronic (pc) and Monocistronic Or- cules and reactions within a cell or within an organism.
ganisms What a struggle this must be. The world of biology has
but a few robust mechanisms that ought to be selected
and utilized whenever possible—one robust mechanism
less activity, more or less transport to an appropriate for coordination must be the use of polycistronic tran-
intracellular location, and so on. scription. Clearly, nothing is more directly aimed at bio-
Speculation and More Speculation chemical coordination than polycistronic transcription.
Francois Jacob said it best in “Evolution and Tinkering” If a cell requires enzymes 1 through 10 to accomplish
[33]. Evolution has a path, but that path is hard to predict some biochemical pathway, what could be more robust
and derives from historical accidents. While there is than to place those enzymes into an operon, express
a perhaps illogical history to evolution, time (at least them coordinately from a single promoter, and allow the
abundant time) can be the driver of metabolic coordina- product (of the translational yield of each gene times
tion. Michael Savageau has spent a lifetime wondering the activity of each enzyme) to provide biochemical co-
about the likelihood that evolution selects, over abun- ordination?
dant time, optimal solutions to serious problems [47]. Nothing is more straightforward than operons to effect
At some important level, time allows playfulness (okay, coordinated biochemistry, and both eubacteria and
call it randomness), and playfulness, when continued archea use operons to accomplish coordinate biochem-
over abundant time, leads to optimal solutions. Jacob’s istry. This leads to a hypothesis (really based on the
analysis deals with the mechanism of evolution but does presumption of robustness in the Savageau sense, with-
not deny the value of abundant time. Savageau argues, out recourse to mathematical modeling—Michael would
persuasively, that time is so abundant that we can forget hate this) that the evolution of polycistronic transcription
sub-optimal solutions if they are not robust. The Sav- is an enormous event that vastly simplifies intracellular
ageau work suggests that evolution cannot hold a “posi- biochemical coordination.
tion” unless it is sufficiently robust to survive playful- The recent literature gives us reason to rejoice. In
some important papers by Tom Blumenthal and his col-ness. Jacob and Savageau represent the extremes of
Figure 4. Monocistronic (mc) Organisms Co-
ordinate Biochemistry with Less Dependence
on Long Transcription Units and More Depen-
dence on Regulation of Short Transcription




leagues [50–52], we learn that C. elegans uses operons. acid-protein linkage map, and we called metabolite-spe-
cific natural aptamers part of the nucleic acid-metaboliteFurthermore, we learn that C. elegans uses operons
less frequently than E. coli but far more frequently than linkage map.
Although the two examples described by Breaker andalmost any other eukaryote. This leads to a tiny exten-
sion of the “tree” of life (Figure 3) and an idea that his colleagues are in E. coli, we expect that similar natu-
ral aptamers provide feedback regulation in monocis-extends Breaker’s work from remnant to novel coordina-
tion mechanisms. We believe that the division of life tronic organisms. Computer search algorithms that seek
structures in RNA [55–57] are one interesting means byinto the three kingdoms occurred prior to selection of
polycistronic life, and that further (isolated within king- which to see aptamers lurking within or outside of pro-
tein coding exons. Similarly, natural aptamers conferringdoms) evolution had the opportunity to independently
evolve polycistronic life as a solution to a big biochemi- end-product inhibition might be sought by scanning for
conserved, structured RNA homologs among thecal problem: coordination. Because both the eubacteria
and the archea have had many more organismic replica- mRNAs encoding sets of proteins involved in common
biosynthetic pathways. The old notions of feedback reg-tion events than have had eukaryotes, only those king-
doms have had the opportunity to optimize coordination ulation are likely to have a renaissance in the next few
years as RNA investigations become even more sophis-through polycistronic life. C. elegans has had the good
fortune, stochastically, to discover and use robustly that ticated.
polycistronic life, but even C. elegans uses polycistronic
Acknowledgmentslife infrequently (about 15% of the genes are transcribed
polycistronically). Interestingly, the coordination achieved
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